Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.30 | 4.81 |
| PEG Ratio (TTM) | 0.07 | -1.08 |
| P/S Ratio (TTM) | 7.28 | 51.51 |
| P/B Ratio (TTM) | 1.04 | 0.94 |
| P/FCF Ratio (TTM) | 6.38 | 18.36 |
| Price to 5YR AVG Earnings Ratio | 57.52 | 26.83 |
| Price to 5YR AVG FCF Ratio | 11.94 | 28.98 |
Profitability (63%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 13.95% | 1.19% |
| ROE (TTM) | 14.63% | 5.36% |
| Net Profit Margin (TTM) | 99.52% | 29.19% |
| ROIC 5YR AVG | 1.73% | 7.77% |
Growth (100%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1,369.35% | 222.61% | 170.85% |
| Revenue | 105.07% | 243.24% | 183.40% |
| Net Income | 1,416.87% | 220.91% | 169.84% |
| Cash Flow | 14.89% | 148.52% | 254.82% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 1.63 |
| Quick Ratio (TTM) | N/A | 1.59 |
| D/E Ratio (TTM) | N/A | 0.72 |
| Interest Coverage (TTM) | N/A | 20.20 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 36.16 | 7.49 |
| LTL to 5YR AVG FCF | N/A | 9.30 |
| Shares Outstanding Growth 5YR AVG | -0.14% | -0.96% |